Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Net Income: 2009-2025

Historic Net Income for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to -$1.9 million.

  • Cumberland Pharmaceuticals' Net Income fell 26.81% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.3 million, marking a year-over-year increase of 69.22%. This contributed to the annual value of -$6.4 million for FY2024, which is 1.78% down from last year.
  • According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' Net Income is -$1.9 million, which was down 165.10% from -$735,207 recorded in Q2 2025.
  • Cumberland Pharmaceuticals' Net Income's 5-year high stood at $1.2 million during Q1 2025, with a 5-year trough of -$6.3 million in Q4 2023.
  • Moreover, its 3-year median value for Net Income was -$1.1 million (2024), whereas its average is -$1.3 million.
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Net Income crashed by 1,204.25% in 2024, and later soared by 165.61% in 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Net Income (Quarterly) stood at $503,318 in 2021, then slumped by 588.70% to -$2.5 million in 2022, then plummeted by 156.21% to -$6.3 million in 2023, then spiked by 69.82% to -$1.9 million in 2024, then declined by 26.81% to -$1.9 million in 2025.
  • Its Net Income stands at -$1.9 million for Q3 2025, versus -$735,207 for Q2 2025 and $1.2 million for Q1 2025.